ACI
Albertsons Companies, Inc.
ACI has slightly lower modeled downside risk, despite its lower overall score.
CELH
Celsius Holdings, Inc.
CELH has the edge over ACI overall, supported by stronger fundamentals and stronger valuation.
ACI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Under pressure |
ACI's revenue is currently stable, but its profitability, cash flow and balance sheet are under pressure.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ACI PE Valuation
ACI has no meaningful PE right now: it lost money over the past year.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
ACI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Growth | |
| Stable | |
| Moderate | |
| Low |
Analysts expect ACI's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over ACI on the outlook, with more favorable earnings and profitability expectations.
ACI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.65 | — |
| Q3 2026 | -$0.03 | -102% |
| Q2 2026 | $0.16 | -90% |
| Q1 2026 | $0.40 | -76% |
| Q4 2025 | $1.55 | -13% |
| Q3 2025 | $1.69 | -1.2% |
| Q2 2025 | $1.64 | -15% |
| Q1 2025 | $1.64 | -26% |
| Q4 2024 | $1.78 | -27% |
ACI has swung to a loss: it lost $0.03 per share over the past year, after a profit the year before.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH has the edge over ACI on earnings quality, reporting a profit while its opponent remains loss making.
ACI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.9B | -0.1% |
| Q2 2026 | $24.9B | +0.2% |
| Q1 2026 | $20.3B | +7.7% |
| Q4 2025 | $19.1B | +1.9% |
| Q3 2025 | $18.9B | +2% |
| Q2 2025 | $24.9B | +2.5% |
| Q1 2025 | $18.8B | +2.5% |
| Q4 2024 | $18.8B | +1.2% |
ACI's revenue grew through 2022 and has held roughly level since: $18.9B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.9% | -0.6 points |
| Q2 2026 | 1.1% | -0.8 points |
| Q1 2026 | -2.5% | -4 points |
| Q4 2025 | 2.6% | -0.2 points |
| Q3 2025 | 1.6% | 0 points |
| Q2 2025 | 1.8% | -0.1 points |
| Q1 2025 | 1.5% | -0.8 points |
| Q4 2024 | 2.8% | -0.3 points |
ACI's operating margin was 0.9% last quarter, down 0.6 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH's revenue has grown year over year for six quarters in a row: $847M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over ACI on profitability, with a higher operating margin.
ACI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $103.9M | -36% |
| Q2 2026 | $206.8M | +22% |
| Q1 2026 | $290.5M | +6% |
| Q4 2025 | -$94.7M | -277% |
| Q3 2025 | $161.7M | +4046% |
| Q2 2025 | $169.8M | -59% |
| Q1 2025 | $274M | -37% |
| Q4 2024 | $53.6M | +$121.4M |
ACI still generates free cash flow, though less than at its 2020 peak: $507M over the past year.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
ACI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.8x | Elevated |
| Q2 2026 | 3.6x | Elevated |
| Q1 2026 | 3.3x | Elevated |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.3x | Moderate |
| Q1 2025 | 2.2x | Moderate |
| Q4 2024 | 2.2x | Moderate |
ACI's net debt is about 3.8 years of its operating earnings (EBITDA), up from 2.3 years a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over ACI on leverage, with a lower net debt burden relative to earnings.
ACI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.2 | Neutral |
| Stochastic | 56.4 | Neutral |
ACI's weekly RSI is 47 (neutral) and its Stochastic is 56 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
ACI PE vs Consumer Defensive Sector
| Metric | ACI | Sector median | Relative |
|---|---|---|---|
| PE | 82x | 19x | 320% above |
| PE % | 100 | 18 | 82 pts above |
ACI has no meaningful PE right now: it lost money over the past year.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over ACI on valuation relative to its sector.
ACI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.7 | 3.7% above |
| 20 week MA | $12.7 | 3.5% above |
| 50 week MA | $15.2 | 13% below |
| 100 week MA | $17.7 | 25% below |
| 200 week MA | $19.3 | 32% below |
ACI has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 32% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
ACI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.5 | $15.8 | +1.9% |
| 2021 | $15.8 | $29.9 | +90% |
| 2022 | $29.9 | $21.1 | -29% |
| 2023 | $21.1 | $23.0 | +8.8% |
| 2024 | $23.0 | $19.9 | -13% |
| 2025 | $19.9 | $17.4 | -13% |
| 2026 YTD | $17.4 | $13.2 | -24% |
ACI has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.